# Binah Capital Group, Inc.: financial statements, quarterly

BCG · Nasdaq · CIK 1953984 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcg.md) · [Financials](/companies/bcg/financials.md) · [Filings](/companies/bcg/filings.md) · [Insiders](/companies/bcg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bcg/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [40.9](/filings/0001410578-24-001986.md) | [39.4 d](/filings/0001410578-25-000604.md) | [40.1](/filings/0001410578-25-001337.md) | [40.0](/filings/0001410578-25-001758.md) | [41.0](/filings/0001104659-25-111462.md) | [43.3 d](/filings/0001104659-26-037897.md) | [48.1](/filings/0001104659-26-062580.md) | [40.6](/filings/0001104659-26-095997.md) | [44.8](/filings/0001104659-25-111462.md) | [48.6 d](/filings/0001104659-26-037897.md) | [47.1](/filings/0001104659-26-062580.md) | [45.4](/filings/0001104659-26-095997.md) |
| Interest expense | $m | not reported | not reported | [1.1](/filings/0001410578-24-000959.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.2)](/filings/0001410578-24-001986.md) | [(0.4) d](/filings/0001410578-25-000604.md) | [0.1](/filings/0001410578-25-001337.md) | [0.2](/filings/0001410578-25-001758.md) | [0.5](/filings/0001104659-25-111462.md) | [0.5 d](/filings/0001410578-25-000604.md) | [0.4](/filings/0001104659-26-062580.md) | [0.1](/filings/0001104659-26-095997.md) | [0.2](/filings/0001104659-25-111462.md) | not reported | [0.8](/filings/0001104659-26-062580.md) | [0.1](/filings/0001104659-26-095997.md) |
| Net income | $m | [0.2](/filings/0001410578-24-001986.md) | [(0.9) d](/filings/0001410578-25-000604.md) | [(2.3)](/filings/0001104659-25-111462.md) | [(0.7)](/filings/0001104659-25-111462.md) | [(1.2)](/filings/0001104659-25-111462.md) | [(1.1) d](/filings/0001104659-26-037897.md) | [1.0](/filings/0001104659-26-095997.md) | [(0.7)](/filings/0001104659-26-095997.md) | [1.8](/filings/0001104659-25-111462.md) | [0.2 d](/filings/0001104659-26-037897.md) | [1.9](/filings/0001104659-26-095997.md) | [0.3](/filings/0001104659-26-095997.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.14)](/filings/0001410578-25-001337.md) | [(0.04)](/filings/0001410578-25-001758.md) | [(0.09)](/filings/0001104659-25-111462.md) | not reported | [0.04](/filings/0001104659-26-062580.md) | [(0.06)](/filings/0001104659-26-095997.md) | [0.08](/filings/0001104659-25-111462.md) | not reported | [0.09](/filings/0001104659-26-062580.md) | [0.00](/filings/0001104659-26-095997.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.14)](/filings/0001410578-25-001337.md) | [(0.04)](/filings/0001410578-25-001758.md) | [(0.09)](/filings/0001104659-25-111462.md) | not reported | [0.04](/filings/0001104659-26-062580.md) | [(0.06)](/filings/0001104659-26-095997.md) | [0.08](/filings/0001104659-25-111462.md) | not reported | [0.09](/filings/0001104659-26-062580.md) | [0.00](/filings/0001104659-26-095997.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | not reported | [67.4](/filings/0001410578-25-000604.md) | [65.8](/filings/0001410578-24-000959.md) | [66.1](/filings/0001410578-24-001477.md) | [67.0](/filings/0001410578-24-001986.md) | [66.7](/filings/0001104659-26-037897.md) | [67.9](/filings/0001410578-25-001337.md) | [67.8](/filings/0001410578-25-001758.md) | [67.6](/filings/0001104659-25-111462.md) | [70.2](/filings/0001104659-26-095997.md) | [71.3](/filings/0001104659-26-062580.md) | [71.2](/filings/0001104659-26-095997.md) |
| Total liabilities | $m | not reported | [62.3](/filings/0001410578-25-000604.md) | [48.0](/filings/0001410578-24-000959.md) | [48.8](/filings/0001410578-24-001477.md) | [49.5](/filings/0001410578-24-001986.md) | [50.5](/filings/0001104659-26-037897.md) | [50.9](/filings/0001410578-25-001337.md) | [51.4](/filings/0001410578-25-001758.md) | [49.5](/filings/0001104659-25-111462.md) | [51.9](/filings/0001104659-26-095997.md) | [50.8](/filings/0001104659-26-062580.md) | [50.4](/filings/0001104659-26-095997.md) |
| Shareholders' equity | $m | [5.8](/filings/0001410578-24-000959.md) | [5.1](/filings/0001104659-26-037897.md) | [17.8](/filings/0001104659-25-111462.md) | [17.3](/filings/0001104659-25-111462.md) | [17.5](/filings/0001104659-25-111462.md) | [16.2](/filings/0001104659-26-095997.md) | [17.0](/filings/0001104659-26-095997.md) | [16.4](/filings/0001104659-26-095997.md) | [18.1](/filings/0001104659-25-111462.md) | [18.3](/filings/0001104659-26-095997.md) | [20.4](/filings/0001104659-26-095997.md) | [20.8](/filings/0001104659-26-095997.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [158 d](/filings/0001410578-24-001986.md) | [2,191 d](/filings/0001410578-25-000604.md) | [(3,136)](/filings/0001410578-25-001337.md) | [1,023 d](/filings/0001410578-25-001758.md) | [(320) d](/filings/0001104659-25-111462.md) | [1,816 d](/filings/0001104659-26-037897.md) | [1,054](/filings/0001104659-26-062580.md) | [62.0 d](/filings/0001104659-26-095997.md) | [932 d](/filings/0001104659-25-111462.md) | [3,103 d](/filings/0001104659-26-037897.md) | [538](/filings/0001104659-26-062580.md) | [1,118 d](/filings/0001104659-26-095997.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001410578-24-001986.md) | [(8.0) d](/filings/0001410578-25-000604.md) | [11.0](/filings/0001410578-25-001337.md) | [7.0 d](/filings/0001410578-25-001758.md) | [0.0 d](/filings/0001104659-25-111462.md) | [67.0 d](/filings/0001104659-26-037897.md) | [8.0](/filings/0001104659-26-062580.md) | [0.0 d](/filings/0001104659-26-095997.md) | [47.0 d](/filings/0001104659-25-111462.md) | [6.0 d](/filings/0001104659-26-037897.md) | [11.0](/filings/0001104659-26-062580.md) | [15.0 d](/filings/0001104659-26-095997.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001410578-25-001337.md) | [16.6](/filings/0001410578-25-001758.md) | [16.6](/filings/0001104659-25-111462.md) | [16.6](/filings/0001104659-26-062580.md) | [16.6](/filings/0001104659-26-095997.md) | [16.7](/filings/0001104659-25-111462.md) | [16.9](/filings/0001104659-26-062580.md) | [17.1](/filings/0001104659-26-095997.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,060,131 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-095997.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.